We are on the beat to find and report just what is happening now in Precision Medicine. Look for this on going report each month as we find articles, commentary, interviews, and events of interest on Precision Medicine. Read more posts on Precision Medicine and follow the hashtag #PrecisionMedicine.
The US National Library of Medicine says “although the term ‘precision medicine’ is relatively new, the concept has been a part of healthcare for many years. For example, a person who needs a blood transfusion is not given blood from a randomly selected donor; instead, the donor’s blood type is matched to the recipient to reduce the risk of complications. Although examples can be found in several areas of medicine, the role of precision medicine in day-to-day healthcare is relatively limited. Researchers hope that this approach will expand to many areas of health and healthcare in coming years.”
What is the difference between precision medicine and personalized medicine? What about pharmacogenomics?
According to the NIH US National Libarary of Medicine, National Research Council, there is a lot of overlap between the terms. Learn more.
Precision Medicine in Action
Tempus Announces the Appointment of Scott Gottlieb, MD, to Its Board of Directors
Tempus (@TempusLabs), a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare, announced that Dr. Scott Gottlieb, MD, has joined its Board of Directors. Dr. Gottlieb will serve as an advisor to Tempus and its leadership team, leveraging his vast experience as a medical policy expert and public health advocate to support Tempus as it harnesses the power and promise of big data and artificial intelligence to personalize patient care.
Seqster Signs 3-year License Agreement of SRP™ to La Jolla Institute of Immunology for Asthma Study
Seqster (@Seqster), the award-winning SaaS-based technology platform enabling consumer-centered health data management, is announcing at HLTH, the nation’s largest conference focused on health innovation in Las Vegas at the MGM Grand, a 3-year licensing deal and partnership with La Jolla Institute of Immunology (LJI) (@ljiresearch) to support the execution of a $6.9 million Asthma study funded by the National Institutes of Health/National Heart, Lung and Blood Institute (NIH NHLBI) that establishes one of only 10 PrecISE Network Clinical Centers nationwide. The new collaboration provides LJI with the Seqster Research Portal (SRP) technology that connects patients, clinicians and researchers to develop personalized treatments and find a cure for asthma by looking at longitudinal data for a 3-year period starting with 5000 participants.
Myriad Genetics to Present Seven Studies at the 2019 National Society of Genetic Counselors Annual Meeting
Myriad Genetics, Inc. (@myriadgenetics), a leader in molecular diagnostics and precision medicine, announced that it will present results from seven studies at the 2019 National Society of Genetic Counselors (NSGC) annual meeting being held Nov. 5–8, 2019 in Salt Lake City.
Amplion’s Machine Learning Platform Accelerates Precision Medicine Collaboration
Amplion (@Amplion), a precision medicine intelligence company, has released Dx:Revenue, a groundbreaking software solution that enables test providers to identify ideal pharmaceutical partnership opportunities at the right time to advance precision medicine collaboration.
HTG Announces the Launch of its New Autoimmune Profiling Assay
HTG Molecular Diagnostics, Inc. (@HTGMolecular) (HTG), a diagnostic company whose mission is to advance precision medicine, announced it will begin taking orders for its new 2,002-gene HTG EdgeSeq Autoimmune Panel, which is expected to be commercially available for purchase in kit form or as a service in HTG’s VERI/O laboratory at the end of October 2019.
On CTO Talk, technology expert Matt Ferrari discusses the issues, challenges, and opportunities transforming healthcare technology today, all from the CTO point of view. Tune in because when CTOs talk, health IT listens. On this episode, Matt talks with Raj Harapanahalli, Head of the Software Center of Excellence, and Vikram Mohan, Sr. Director of Product Management, Roche Diagnostics about collaboration in the cloud for improved, indivdiualized cancer care.
All of Us Research Program
Let’s learn more about health! What’s #precisionmedicine? It’s about creating health practices + care tailored to the individual. Helping researchers get the info to make this possible is the goal of our program. More at https://t.co/7uNue4oLpP. #JoinAllofUs #HealthLiteracyMonth pic.twitter.com/BKvVR1PgVS
— AllofUsResearch (@AllofUsResearch) October 25, 2019
15th Annual Personalized Medicine Conference at Harvard Medical School
November 13-14, 2019
Harvard Medical School, Boston MA
Register for this event.
The 15th Annual Personalized Medicine Conference will convene the world’s leading researchers, investors, industry executives, policy experts, payers, clinicians, and patient advocates to define the landscape and outlook for personalized medicine in science, business, and policy.
All of Us Research Program
Yes! You can #JoinAllofUs even if you’re in other health studies. If you are in another study, you may want to talk with your health care team before joining. All of Us is not a study, so you should still be able to join. Learn more at https://t.co/7uNue4oLpP. pic.twitter.com/GPbtLnPebp
— AllofUsResearch (@AllofUsResearch) October 24, 2019
Precision Medicine Initiative
The National Library of Medicine also tells us the “Precision Medicine Initiative is a long-term research endeavor, involving the National Institutes of Health (NIH) and multiple other research centers, which aims to understand how a person’s genetics, environment, and lifestyle can help determine the best approach to prevent or treat disease.” The Initiative has both short and long term goals.
The Journal of Precision Medicine (@JournPrecMed)
The world’s first print publication to discuss the many key global issues surrounding this rapidly evolving landscape. It does so by connecting both ends of the life science continuum – the compelling discoveries being realized in molecular research with the critical needs of the patient in the clinical setting.
The Personalized Medicine Coalition (@permedcoalition)
PMC, representing innovators, scientists, patients, providers and payers, promotes the understanding and adoption of personalized medicine concepts, services and products to benefit patients and the health system.